Apoptosis in human monocytic THP
Introduction
Apoptosis is a physiological form of cell death characterised by cell shrinkage, nuclear condensation and fragmentation (Wyllie et al, 1984; Arends and Wyllie, 1991) . Apoptosis is important in normal development and tissue homeostasis and perturbation of the apoptotic process may be important in many human diseases, including cancer (Wyllie et al, 1984; Arends and Wyllie, 1991) . In the nematode, Caenorhabditis elegans, 131 cells die during development. The gene, ced-3, is required for these cells to die and it encodes a protein, CED-3, with considerable sequence homology to mammalian interleukin-1b-converting enzyme protease (ICE now termed caspase-1) (Yuan et al, 1993; Alnemri et al, 1996) . Subsequently, a family of caspases has been identified, all containing an active QACXG (X=R, G or Q) pentapeptide motif (reviewed by Kumar, 1995; Martin and Green, 1995; Thornberry and Molineaux, 1995; Cohen, 1997) . All caspases are synthesized as inactive proenzymes, which are processed proteolytically at aspartic acid (Asp) cleavage sites to generate a large and a small subunit, which form the active enzyme (Thornberry and Molineaux, 1995; Cohen, 1997) . Activated caspases also cleave their substrates after Asp residues. Three sub-families of caspases have been identified, the CED-3 subfamily comprising caspase-3 (CPP32/Yama/apopain), caspase-7 (Mch3/ICE-LAP3/CMH-1), caspase-6 (Mch2) and caspase-9, the caspase-1 subfamily comprising caspase-1, caspase-4 (Tx/ICE rel-II/ Ich2) and caspase-5 (ICE rel-III) and the NEDD-2 subfamily comprising caspase 2 (Ich-1) and its murine homologue, NEDD-2 .
During the early stages of apoptosis, several nuclear proteins are degraded including histones, lamins, DNA topoisomerase I and II, poly(ADP-ribose) polymerase (PARP) and U1 small ribonucleoprotein. PARP cleavage has proved to be a useful early marker of apoptosis (Kaufmann, 1989; Kaufmann et al, 1993) . In addition, two tumour suppressor gene products have been shown to be cleaved during apoptosis; the retinoblastoma susceptibility gene product Rb and the adenomatous polyposis coli gene product APC (Browne et al, 1994) . The Rb tumour suppressor gene encodes a nuclear phosphoprotein that participates in the transition between G1 and S-phases of the cell cycle (reviewed in Ewen, 1994) . Rb has been proposed to play a role in protecting cells from apoptosis (Haas-Kogan et al, 1995; Haupt et al, 1995) , possibly through its interactions with E2F as free E2F may induce apoptosis (Qin et al, 1994; Wu and Levine, 1994; Almasan et al, 1995) .
APC protein is a cytoplasmic protein, which like Rb, is constitutively expressed in many tissue types, for example, lung, breast, prostate, pancreas, cervix, lymphoid and colon (Smith et al, 1993) . The function of the APC protein is not known but it may play a role in regulating cell-cell adhesion through its binding to b-catenin (Rubinfeld et al, 1993; Su et al, 1993) . APC competes for b-catenin binding with Ecadherin (Rubinfeld et al, 1993) . The binding of b-catenin to E-cadherin activates cadherin mediated cell-cell adhesion (reviewed in Birchmeier et al, 1995) . It is important to note however that E-cadherin is not expressed by all cell types expressing APC, for example lymphoid tissues. Interestingly APC may modulate the expression of b-catenin and has thus been implicated to have a role in signal transduction (reviewed by Kinzler and Vogelstein, 1996) . In addition, APC binds to the tubulin cytoskeleton and has therefore been implicated to have a role in the control of cell shape (Munemitsu et al, 1994; Smith et al, 1994) . APC also binds to DLG, the human homologue of the Drosophila discs large protein and has been suggested to have a role in neurone functioning (Matsumine et al, 1996) . APC protein is cleaved in apoptotic cells (Browne et al, 1994) . Although the functional significance of this cleavage is not fully understood, it suggests that APC may have a role in apoptosis (Browne et al, 1994) . Consistent with this suggestion, fulllength APC has recently been demonstrated to induce apoptosis in the colorectal tumour cell line HT29, which expresses two truncated APC proteins (Morin et al, 1996) .
Apoptosis in the human monocytic cell line THP.1 can be induced with a wide range of stimuli (Zhu et al, 1995) . In these cells, the trypsin-like serine protease inhibitor, Natosyl-L-lysinyl chloromethyl ketone (TLCK), enhances apoptosis induced by cycloheximide, an inhibitor of protein synthesis or thapsigargin, a microsomal Ca 2+ -ATPase inhibitor. In contrast, the induction of apoptosis by the DNA topoisomerase II inhibitor, etoposide is inhibited by TLCK (Zhu et al, 1995) . Apoptosis induced by DNA damaging agents in HL-60 and U937 cells was also inhibited by TLCK (Gong et al, 1993; An and Dou, 1996) , whereas apoptosis in HL-60 cells induced by cycloheximide was potentiated by TLCK (Gong et al, 1993) . Previously, we reported cleavage of APC and Rb proteins during apoptosis in three cell types, however the timing of these events in the apoptotic process has not been studied (Browne et al, 1994) . Studying the timing of APC and Rb cleavage is important as it may give a clue to the importance of APC and Rb in apoptosis (Chen et al, 1997) . In the present study apoptosis was induced in THP.1 cells using divergent stimuli and we have investigated the timing of APC and Rb cleavage relative to poly(ADP-ribose) polymerase (PARP) proteolysis, an early marker of apoptosis (Kaufmann et al, 1993) . We have also utilised the two caspase inhibitors, benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethyl ketone (Z-VAD.FMK) and Acetyl-Tyr-Val-Ala-Asp chloromethyl ketone (YVAD.CMK), to investigate whether one or more caspases are involved in the pathways leading to APC and Rb cleavage in apoptosis.
Results
APC and Rb proteolysis in THP.1 cell apoptosis induced by diverse stimuli Apoptosis was induced in THP.1 cells by incubation for up to 4 h with cycloheximide/TLCK (25 mM/100 mM) or thapsigargin/TLCK (100 nM/100 mM) or by incubation for up to 6 h with etoposide (25 mM) as previously described (Zhu et al, 1995) . Protein samples were prepared from control and treated cells and the expression of APC and Rb proteins examined. APC protein expression was measured using the amino-terminal antibody FE9 (Smith et al, 1993) and Rb protein expression was detected using the Rb245 antibody. In apoptotic colonic epithelial cells, APC is cleaved to a 90 kDa protein fragment and Rb is cleaved to 43 kDa and 30 kDa protein fragments (Browne et al, 1994) . Following exposure of THP.1 cells for 4 h to apoptotic stimuli, the 90 kDa cleavage product of APC protein ( Figure 1 ) and the 43 kDa and 30 kDa cleavage products of the Rb protein ( Figure 2) were also detected.
The timing of APC and Rb cleavage was determined relative to PARP cleavage and apoptosis. Cycloheximide/ TLCK, thapsigargin/TLCK and etoposide all induced apoptosis in THP.1 cells (Table 1 ) and this occurred in a time dependent manner. Protein samples were prepared after 1, 2 and 4 h treatment with cycloheximide/TLCK and thapsigargin/TLCK, and after 2, 4 and 6 h treatment with etoposide as etoposide-induced apoptosis was delayed compared to the other stimuli. In untreated control cells almost all the PARP and APC were present as intact and TLCK (100 mM). Protein samples were prepared at these times and separated on either 3% agarose or 10% acrylamide gels to detect APC proteolysis (a and b respectively) or 7.5% acrylamide gel to detect PARP proteolysis (c). APC protein was detected using the amino terminal antiody FE9 and PARP protein was detected using the PARP antibody kindly provided by Dr. G Poirier. The 180 kDa and 90 kDa cleavage products of APC and the 85 kDa cleavage product of PARP are indicated. Although the 300 kDa intact APC protein was not transferred from the acrylamide gels, the 90 kDa cleaved fragment was more clearly observed proteins with little or no cleavage products being detected ( Figure 1 ). After 2 h treatment with cycloheximide/TLCK, proteolysis of intact PARP (116 kDa) to its signature 85 kDa fragment was detected above control levels, whereas after 4 h treatment most but not all of the PARP was cleaved to this size of fragment ( Figure 1c ). Similarly, after 2 and 4 h treatment with cycloheximide/TLCK, loss of intact APC protein was accompanied by appearance of a 90 kDa APC cleavage product (Figure 1a and b). Interestingly in this cell line, in addition to the 90 kDa protein, a further band at approximately 180 kDa was detected in apoptotic cells ( Figure 1a ). This 180 kDa protein was not detected in three other apoptosis systems when APC was cleaved to a 90 kDa protein fragment (Browne et al, 1994) and may represent another cleavage product of the APC protein. These data suggested that the APC protein cleavage product accumulated at a similar time to the PARP cleavage product. The results shown for cycloheximide/TLCK were representative of the results found with either thapsigargin/TLCK or etoposide. Proteolysis of PARP and APC was detected above control levels after 2 h treatment with thapsigargin/TLCK and 4 h treatment with etoposide (data not shown). The timing of APC and PARP proteolysis was coincident with the detection of morphological apoptosis assessed by flow cytometry (H. Zhu -personal communication) . Rb protein cleavage has been previously shown to occur in apoptotic cells (Browne et al, 1994; An and Dou, 1996) . Using the Rb245 antibody to detect Rb proteolysis, Rb protein was cleaved to 43 kDa and 30 kDa products in THP.1 cells exposed for 4 h to thapsigargin/TLCK ( Figure  2b To determine whether the lower molecular weight form of Rb was due to either a change in phosphorylation state (An and Dou, 1996) , or due to the carboxy terminal cleavage of Rb (Janicke et al, 1996; Chen et al, 1997; Tan et al, 1997) , samples were separated on a 6.5% acrylamide gel, probed with the Rb antibody Rb245 and reprobed with the carboxy terminal Rb antibody C-15. If the lower molecular weight form of Rb was due to an alteration in phosphorylation state, then the lower molecular weight protein should be detectable with both antibodies. However, if it was due to cleavage of the carboxy terminal region of Rb, then the protein would only be detected with the Rb245 antibody. When separated on a 6.5% acrylamide gel, an immunoreactive band was detected with a lower molecular weight than hypophosphorylated Rb ( Figure 2a ). As this was only detected with the Rb245 antibody, it suggested that the protein fragment was due to cleavage of the carboxy terminal region of Rb. This primary cleavage of Rb was observed after 2 h treatment with the apoptotic stimuli prior to the secondary cleavage of Rb to the 43 kDa and 30 kDa protein products ( Figure 2 and data not shown).
As treatment of THP.1 cells for 4 h with cycloheximide/ TLCK did not result in 100% apoptosis (Table 1) , a mixed population of cells with normal or apoptotic morphology was present. Some full-length APC (data not shown) and intact PARP protein was always detected at the 4 h time point as well as their cleavage products (Figure 1) . In order to determine whether the remaining full-length protein was due to non-apoptotic cells in the mixed cell population, cells Figure 2 Rb cleavage during thapsigargin/TLCK-induced apoptosis. THP.1 cells were incubated for up to 4 h either alone or in the presence of thapsigargin (THG) (100 nM) and TLCK (100 mM). Protein samples were prepared at the indicated times and separated on a 6.5% and 10% acrylamide gel to detect (a) Rb primary carboxy terminal cleavage and (b) Rb secondary cleavage respectively. Rb protein was detected using the Rb245 antibody. The carboxy terminal cleaved product, 43 kDa and 30 kDa cleaved products of Rb are indicated (2) THP.1 cells were incubated for 1 h alone or in the presence of Z-VAD.FMK (50 mM) or YVAD.CMK (100 mM). They were then further incubated for 4 h in the presence of cycloheximide (25 mM) together with TLCK (100 mM) or thapsigargin (100 nM) together with TLCK (100 mM). In the case of etoposide, cells were incubated for 6 h in order to induce a higher level of apoptosis. The percentage of apoptotic cells was assessed by¯ow cytometry as described in Materials and Methods. Results are expressed as the mean+S.E. and the number of experiments indicated in brackets were sorted using a flow cytometer into morphologically normal (low blue fluorescence) and morphologically apoptotic (high blue fluorescence) cell fractions as described in the methods. THP.1 cells were treated with cycloheximide/TLCK for 3 h, which resulted in approximately 40% apoptotic cells, and then sorted into normal and apoptotic cells. In morphologically normal cells, PARP was detected predominantly as the full-length 116 kDa protein, whereas in apoptotic cells it was present as the cleaved 85 kDa PARP fragment (MacFarlane et al, 1997) . In the unsorted cells, APC protein was cleaved to a 90 kDa fragment and the carboxy terminus of Rb was also cleaved compared to control cells (compare Figure 3a and b, lanes 1 and 2). In the morphologically normal sorted cells, fulllength APC was detected (data not shown) with only a small amount of the 90 kDa fragment (Figure 3a 
Z-VAD.FMK inhibits proteolysis of PARP, APC and Rb
Having shown that APC and Rb proteins were cleaved in THP.1 cells during apoptosis, the possible role of caspases in this cleavage was investigated using the caspase inhibitor Z-VAD.FMK. Z-VAD.FMK inhibits apoptosis in THP.1 cells as measured by flow cytometry, PARP proteolysis, formation of large kilobase fragments of DNA and internucleosomal cleavage of DNA (Zhu et al, 1995) . Pretreatment of THP.1 cells with Z-VAD.FMK (50 mM) for 1 h completely inhibited apoptosis induced by diverse stimuli ( Table 1) 
YVAD.CMK inhibits APC and Rb secondary cleavage but not PARP proteolysis or Rb primary cleavage
In order to gain further insight into the nature of the caspase(s) responsible for the cleavage of APC and Rb, we also used the caspase inhibitor YVAD.CMK. YVAD.CHO was designed initially to reversibly inhibit caspase-1 with a Ki in the nanomolar range (Thornberry et al, 1992) . Using the same tetrapeptide motif, YVAD.CMK was synthesized as an irreversible inhibitor of caspase-1 but it also inhibits other caspases including the proteolytic activity described as prICE (Lazebnik et al, 1994) . Prior to exposure to different apoptotic stimuli, THP.1 cells were pretreated for 1 h with YVAD.CMK (100 mM), a concentration which inhibits Rb proteolysis in HL-60 cells and U937 cells (An and Dou, 1996) . YVAD.CMK did not inhibit apoptosis as assessed by flow cytometry (Table 1) but it partially inhibited internucleosomal cleavage of DNA (data not shown) in agreement with previous results (Zhu et al, 1995) . All three apoptotic stimuli again induced extensive cleavage of PARP to an 85 kDa fragment (Figure 5a lanes 3, 5 and 7). However, YVAD.CMK (100 mM) caused a slight but clearly incomplete inhibition of the proteolysis of PARP induced by the three apoptotic stimuli (Figure 5a 
Discussion APC proteolysis in apoptosis
The human monocytic THP.1 cell line expressed full-length APC protein, which was cleaved to a 90 kDa protein fragment during apoptosis induced by diverse stimuli (Figures 1, 4 and 5), consistent with the similar cleavage of APC in spontaneous apoptosis in colonic epithelial cell lines and in a SV40 transformed fibroblast cell line, and in calcium ionophore-induced apoptosis in a Burkitt lymphoma cell line (Browne et al, 1994) . Although we have previously demonstrated cleavage of APC protein during apoptosis, when this proteolysis occurred relative to morphological and biochemical markers of apoptosis was unclear. Also the type of protease involved in APC cleavage was not known. In this study, cleavage of APC protein occurred at a similar time to proteolysis of PARP which has been proposed to be an early event in apoptosis (Kaufmann et al, 1993) . In addition, we have shown that the two different caspase inhibitors, Z-VAD.FMK and YVAD.CMK, had markedly different effects on the cleavage of APC and PARP. Z-VAD.FMK, as well as inhibiting PARP proteolysis (Zhu et al, 1995; MacFarlane et al, 1997) , also inhibited APC proteolysis (Figure 4 ). In contrast, YVAD.CMK (100 mM) inhibited APC but not PARP cleavage ( Figure 5 ). That both Z-VAD.FMK and YVAD.CMK inhibited APC cleavage suggests that a caspase may cleave APC or may be involved in the pathway leading to APC cleavage. In addition, the data suggests that APC protein may be cleaved by a different caspase(s) from that responsible for the cleavage of PARP. However, we cannot totally exclude the possibility that APC and PARP were cleaved by the same caspase but cleavage of PARP by this enzyme was much less susceptible to inhibition by YVAD.CMK. Although the precise cleavage site(s) of APC are not known, potential caspase cleavage sites exist near the region of APC postulated to be cleaved during apoptosis. Proteolysis of PARP in intact cells is primarily carried out by caspase-3 (CPP32) and/or caspase-7 (Mch3) (Fernandes- Alnemri et al, 1995a; Nicholson et al, 1995; Tewari et al, 1995) , although other caspases including recombinant caspase-1 (ICE), caspase-4 (TX) and caspase-6 (Mch2) when used at high concentrations can also cleave PARP (Fernandes-Alnemri et al, 1995b; Gu et al, 1995) . In some model systems, the lamin protease is two orders of magnitude more sensitive to inhibition by YVAD.CMK than the PARP protease . Caspase-6 (Mch2) but not caspase-3 or caspase-7 is capable of cleaving lamins (Orth et al, 1996; . In THP.1 cells undergoing apoptosis, cleavage of lamins is accompanied by the activation/processing of caspase-6 and YVAD.CMK inhibited the cleavage of the lamins but not the loss of intact caspase-6 suggesting that it inhibited the activity of caspase-6 but not its processing (MacFarlane et al, 1997) . The susceptibility of cleavage of APC to inhibition by YVAD.CMK suggests that caspase-6 may be a possible candidate although the involvement of other caspases cannot be excluded. Further studies with purified caspases are necessary to clearly identify the enzyme(s) which cleaves APC.
The functional significance of APC cleavage in apoptosis is currently not known. Most of the known functional domains of APC are lost in proteolysis to the 90 kDa protein, including the catenin binding site, the region involved in modulation of b-catenin expression, and the EB1, DLG and cytoskeleton binding domains. Interestingly, APC has been demonstrated to bind tubulin and affect the construction of the tubulin cytoskeleton (Munemitsu et al, 1994; Smith et al, 1994) . Cleavage of APC during apoptosis may therefore regulate some of the cytoplasmic changes that occur during apoptosis. Although the significance of APC proteolysis is unclear, we have previously suggested that APC may have a role in apoptosis/cell survival (Browne et al, 1994) . APC protein is expressed in many normal cell types and its expression has been shown to increase in differentiated cells (Smith et al, 1993) . In particular, in the colonic crypt APC protein expression has been shown to increase as the cells migrate towards the top of the crypt (Smith et al, 1993) . It was suggested that the increased APC expression may result in apoptosis in the migrating cells as recent studies have shown that expression of wild-type APC induced apoptosis in a colorectal tumour cell line expressing two mutant APC proteins (Morin et al, 1996) . Clearly it would be of interest to determine whether APC has a role in the induction of apoptosis in normal cells as well as in tumour cells. The expression of wild-type APC in colorectal carcinoma cells could result in apoptosis as a result of conflicting signals brought about by the introduction of a wild-type tumour suppressor gene.
Although APC has been shown to be cleaved during apoptosis, APC proteolysis is not necessary for apoptosis to occur. This is because YVAD.CMK was shown to inhibit APC proteolysis but did not inhibit morphological apoptosis. Z-VAD.FMK inhibits apoptosis at an early stage in the apoptosis programme (MacFarlane et al, 1997) . This may possibly be after the cells are committed to die but prior to the morphological and biochemical measurements of apoptosis (McCarthy et al, 1997) . YVAD.CMK inhibits only some features of the apoptotic phenotype, such as cleavage of lamins MacFarlane et al, 1997) and cleavage of APC and Rb possibly because its most susceptible targets are only activated at a later stage of the apoptotic programme. YVAD.CMK also inhibits internucleosomal cleavage of DNA (Zhu et al, 1995) . Thus APC cleavage and DNA laddering may result from activation of a similar caspase(s). Further work is necessary in order to determine the significance of APC in apoptosis.
Rb proteolysis in apoptosis
In this study, we have demonstrated that Rb protein is cleaved twice during apoptosis in THP.1 cells. Initially, it is cleaved early in the apoptotic process at a similar time to PARP and APC proteolysis. The size of the Rb cleavage product is consistent with the carboxy-terminal cleavage of Rb at the DEAD;G site reported by Janicke et al (1996) , Chen et al (1997) and Tan et al (1997) . The secondary cleavage of Rb occurred later than PARP and APC proteolysis, coinciding with the detection of internucleosomal DNA cleavage. During the secondary cleavage, Rb protein was cleaved to 43 kDa and 30 kDA protein products, consistent with results found in three other apoptosis systems (Browne et al, 1994) . This is the first report demonstrating that the primary and secondary cleavage of Rb occur with different timing in apoptosis. The functional significance of the primary and secondary cleavage of Rb protein in apoptosis is not known. Interestingly, it has been demonstrated that the carboxy-terminal cleaved form of Rb was no longer able to bind Mdm-2, however it was still able to bind E2F (Janicke et al, 1996; Chen et al, 1997) . This may suggest that loss of Mdm-2 binding by Rb is an important event in apoptosis. Alternatively, retention of E2F binding by Rb may be important early in apoptosis. In support of this suggestion, Chen et al (1997) demonstrated that carboxy terminal cleavage of Rb enhanced E2F binding to Rb. The selective inactivation of Rb functions may have a role in ordering the timing of events in the apoptosis process.
The two caspase inhibitors had different effects on the primary and secondary cleavage of Rb. Z-VAD.FMK completely inhibited cleavage of Rb, however, YVAD.CMK inhibited the secondary cleavage but not the primary carboxy-terminal cleavage. This is the first report of a caspase inhibitor blocking secondary but not primary cleavage of Rb. Caspase-3 and/or caspase-7 have been proposed to cleave the carboxy terminal fragment of Rb based partly on the presence of the DEAD;G sequence at the Rb cleavage site (Janicke et al, 1996; Chen et al, 1997; Tan et al, 1997) , similar to the DEVD;G sequence which is cleaved in PARP (Lazebnik et al, 1994) , and compatible with the presence of a DXXD motif commonly found in most caspase-3 and caspase-7 substrates (Cohen, 1997) . Our findings that YVAD.CMK did not inhibit PARP cleavage or Rb carboxy terminal cleavage ( Figure 5 ) further supports the suggestion that the initial cleavage of Rb is mediated by caspase-3 and/or caspase-7. The identity of the caspase responsible for the secondary cleavage of Rb is not known. The different inhibitor profiles may suggest a different caspase was responsible for the primary and secondary cleavage. The susceptibility of this secondary cleavage to YVAD.CMK again suggested that caspase-6 may be involved. However, the different time course of the appearance of the 90 kDa fragment of APC and 43 kDa and 30 kDa fragments of Rb also suggested that different caspases may be involved in these cleavages. Thus our data provide indirect evidence for the involvement of at least three caspases in the cleavage of APC and Rb. Firstly, caspase-3 and/or caspase-7, which is responsible for the C-terminal cleavage of Rb as well as for PARP proteolysis, secondly an unidentified caspase which is responsible for the early cleavage of APC to a 90 kDa fragment and thirdly a caspase responsible for the later cleavage or Rb to 43 kDa and 30 kDa fragments. Both the latter caspases are susceptible to inhibition by YVAD.CMK but are activated at different times in the apoptotic process. Again, we cannot exclude that these cleavages may be mediated by the same caspase which has different affinities to different substrates depending on factors, such as accessibility. Further studies using purified caspases will be necessary to clearly identify which proteases are responsible for the primary and secondary cleavage of Rb.
To summarise, we have demonstrated that APC protein was cleaved at a similar time to PARP proteolysis. Rb protein was sequentially cleaved during apoptosis with the initial cleavage occurring at a similar time to that of PARP cleavage, while the secondary cleavage occurred approximately 2 h later. Z-VAD.FMK inhibited all the morphological and biochemical features of apoptosis measured, including PARP, APC and Rb protelysis whereas YVAD.CMK inhibited APC proteolysis and the secondary cleavage of Rb but not PARP proteolysis, the primary cleavage of Rb or morphological apoptosis as assessed by flow cytometry. The data presented suggests for the first time that a caspase may cleave APC protein or may be involved in the pathway leading to APC proteolysis. Our original observation that APC was cleaved in apoptosis and the recent observation that APC induces apoptosis (Morin et al, 1996) indicates that APC may have an important role in apoptosis. Further work will be necessary to determine the significance of APC in apoptosis.
Materials and Methods

Materials
All medium and serum used were purchased from Gibco (Paisley, UK). TLCK was obtained from Boehringer Mannheim UK (Lewes, UK), the caspase inhibitors Z-VAD.FMK and YVAD.CMK were obtained from Enzyme Systems Inc. (Dublin, CA, USA) and Bachem (Bubendorf, Switzerland) respectively. The purified mouse monoclonal antibody to APC, FE9 was purchased from Oncogene Science, Inc (Cambridge, MA, USA), purified mouse monoclonal to Rb, Rb245 was obtained from PharMingen (Cambridge, UK), rabbit polyclonal antibody to the carboxy terminus of Rb, C-15 was obtained from Santa Cruz Biotechnology, Inc (California) and the antibody to PARP (rabbit antiserum 318) was a kind gift from Dr. G Poirier (Laval University, Quebec, Canada).
Cell culture
The human monocytic cell line THP.1 was obtained from Dr. K Whaley, University of Leicester and grown as described previously (Zhu et al, 1995) . Apoptosis was induced in THP.1 cells by incubation for up to 4 h with cycloheximide/TLCK (25 mM/100 mM) or thapsigargin/TLCK (100 nM/100 mM) or by incubation for up to 6 h with etoposide (25 mM). In experiments with caspase inhibitors, cells were preincubated for 1 h with Z-VAD.FMK (50 mM) or YVAD.CMK (100 mM) in order to facilitate their entry into cells. Z-VAD.FMK was supplied with the Asp in the P1 position being esterified in order to increase cell permeability.
Apoptosis assessed by¯ow cytometry
The method for the detection, separation and quantitation of morphologically normal and apoptotic THP.1 cells has been previously described (Zhu et al, 1995) . Cells were stained with Hoechst 33342 (1.5 mg/ml) and propidium iodide (0.05 mg/ml) and analyzed using a Becton Dickinson FACS Vantage flow cytometer (Zhu et al, 1995) . Nonviable cells, as indicated by propidium iodide inclusion, were gated out (mean 3.2%+0.6). Viable cells were displayed as a cytogram of blue fluorescence versus forward light scatter. The cells exhibiting low blue fluorescence appeared morphologically normal under fluorescence microscopy whereas the high blue cells displayed a typical apoptotic morphology (Zhu et al, 1995) . The increased Hoechst staining reflects a change in membrane permeability (Ormerod et al, 1993) . Cells were also sorted into two populations, one which exhibited low blue fluorescence and was morphologically normal and the other which exhibited high blue fluorescence and was morphologically apoptotic (MacFarlane et al, 1997) .
Protein sample preparation from whole cells THP.1 cells (10 6 ) were centrifuged at 13 000 r.p.m., for 3 min and washed in PBS. The cells were then resuspended in 50 ml of gel sample buffer (63 mM Tris. HCl, pH 6.8, 10% glycerol, 5% 2-mercaptoethanol, 2% SDS and 0.025% bromophenol blue), boiled for 5 min and stored at 7208C.
SDS ± PAGE Western blotting
Proteins were resolved by SDS ± PAGE, transferred onto PVDF membrane (Millipore, Watford, UK) and probed with monoclonal antibodies as described previously (Browne et al, 1994) . 10% Acrylamide gels were used to look for the cleavage products of APC and Rb proteins, however 7.5% acrylamide gels were used to investigate PARP cleavage (Kaufmann et al, 1993) . In addition, 6.5% acrylamide gels were used to distinguish between the hyperphosphorylated and carboxy terminal cleaved forms of Rb (Janicke et al, 1996) .
Agarose Western blotting
Full-length APC protein has a molecular weight of 300 kDa and is difficult to transfer using standard SDS ± PAGE Western blotting techniques. Samples were therefore run on 3% agarose gels using the previously described method (Smith et al, 1993) . Although this method detects both intact and cleaved APC products, the acrylamide blots were better for detecting the 90 kDa cleaved product and were therefore used in most of the experiments.
